This is not the most recent version of the article. View current version (28 FEB 2013)

Intervention Review

Cyclophosphamide versus methylprednisolone for treating neuropsychiatric involvement in systemic lupus erythematosus

  1. Virginia Fernandes Moça Trevisani1,*,
  2. Aldemar A Castro2,
  3. João JFNN Ferreira Neves Neto3,
  4. Álvaro N Atallah4

Editorial Group: Cochrane Musculoskeletal Group

Published Online: 19 APR 2006

Assessed as up-to-date: 20 FEB 2006

DOI: 10.1002/14651858.CD002265.pub2


How to Cite

Trevisani VFM, Castro AA, Ferreira Neves Neto JJFNN, Atallah ÁN. Cyclophosphamide versus methylprednisolone for treating neuropsychiatric involvement in systemic lupus erythematosus. Cochrane Database of Systematic Reviews 2006, Issue 2. Art. No.: CD002265. DOI: 10.1002/14651858.CD002265.pub2.

Author Information

  1. 1

    UNISA (Santo Amaro University)/UNIFESP (Paulista Medicine School), Rheumatology/Internal Medicine and Therapeutics, Jardim Marajoara, Sao Paulo, Brazil

  2. 2

    State University of Heath Science, Department of Public Health, Maceió, Alagoas, Brazil

  3. 3

    Federal University of São Paulo, Surgery, São Paulo, Lapa, Brazil

  4. 4

    Universidade Federal de São Paulo / Escola Paulista de Medicina, Brazilian Cochrane Centre, São Paulo, SP, Brazil

*Virginia Fernandes Moça Trevisani, Rheumatology/Internal Medicine and Therapeutics, UNISA (Santo Amaro University)/UNIFESP (Paulista Medicine School), Rua Marie Satzke 119, Jardim Marajoara, Sao Paulo, 04664-150, Brazil. vmoca@uol.com.br. cochrane.dmed@epm.br.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 19 APR 2006

SEARCH

This is not the most recent version of the article. View current version (28 FEB 2013)

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Smiljana Bundovska, Neurolupus, Macedonian Medical Electronic Journal, 2015,

    CrossRef

  2. 2
    Erasmia Broussalis, Eugen Trinka, Jörg Kraus, Mark McCoy, Monika Killer, Treatment strategies for vasculitis that affects the nervous system, Drug Discovery Today, 2013, 18, 17-18, 818

    CrossRef

  3. 3
    Jacob M. Van Laar, Kelley's Textbook of Rheumatology, 2013,

    CrossRef

  4. 4
    Lily Lim, Sarah Lippe, Earl Silverman, Pediatric Neurology Part II, 2013,

    CrossRef

  5. 5
    Oscar-Danilo Ortega-Hernandez, Yehuda Shoenfeld, Mixed connective tissue disease: An overview of clinical manifestations, diagnosis and treatment, Best Practice & Research Clinical Rheumatology, 2012, 26, 1, 61

    CrossRef

  6. 6
    Deborah M. Levy, Sylvia Kamphuis, Systemic Lupus Erythematosus in Children and Adolescents, Pediatric Clinics of North America, 2012, 59, 2, 345

    CrossRef

  7. 7
    Zeev Blumenfeld, Or Mischari, Naomi Schultz, Nina Boulman, Alexandra Balbir-Gurman, Gonadotropin Releasing Hormone Agonists May Minimize Cyclophosphamide Associated Gonadotoxicity in SLE and Autoimmune Diseases, Seminars in Arthritis and Rheumatism, 2011, 41, 3, 346

    CrossRef

  8. 8
    Earl Silverman, Allison Eddy, Textbook of Pediatric Rheumatology, 2011,

    CrossRef

  9. 9
    Gerard Espinosa, Andrea Mendizábal, Sonia Mínguez, Cristina Ramo-Tello, Jaume Capellades, Alejandro Olivé, Ricard Cervera, Transverse Myelitis Affecting More Than 4 Spinal Segments Associated with Systemic Lupus Erythematosus: Clinical, Immunological, and Radiological Characteristics of 22 Patients, Seminars in Arthritis and Rheumatism, 2010, 39, 4, 246

    CrossRef

  10. 10
    SY Shen, Relationship between lupus headache and headache due to internal injury in traditional Chinese medicine, Journal of Chinese Integrative Medicine, 2009, 7, 5, 407

    CrossRef

  11. 11
    Jean V Craig, Clare E Pain, Michael William Beresford, Disease modifying immunosuppressant drugs for juvenile-onset systemic lupus erythematosus, The Cochrane Library,
  12. 12
    S. M. Breathnach, C. H. Smith, R. J. G. Chalmers, R. J. Hay, Systemic Therapy,